Trillium Therapeutics Inc (NASDAQ:TRIL)

17.64
Delayed Data
As of 3:59pm ET
 -0.14 / -0.79%
Today’s Change
0.29
Today|||52-Week Range
18.73
+1,612.62%
Year-to-Date
No recent news for Trillium Therapeutics Inc.

Today’s Trading

Previous close17.78
Today’s open18.19
Day’s range17.52 - 18.33
Volume151,837
Average volume (3 months)1,951,188
Market cap$1.8B
Data as of 3:59pm ET, 11/23/2020

Growth & Valuation

Earnings growth (last year)+30.11%
Earnings growth (this year)-29.92%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales208.97
Price/Book--

Competitors

 Today’s
change
Today’s
% change
MYGNMyriad Genetics Inc+0.43+2.50%
LNTHLantheus Holdings In...+0.35+2.80%
VIVOMeridian Bioscience ...-1.42-7.47%
CLDXCelldex Therapeutics...+1.36+6.83%
Data as of 3:59pm ET, 11/23/2020

Financials

Next reporting dateMarch 5, 2021
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$124.0K
Annual profit (last year)-$41.6M
Net profit margin-33,566.13%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Mississauga, Ontario

Forecasts